iShares Genomics Immunology and Healthcare ETF Rating $22.54 +0.02 (+0.09%) Closing price 04:10 PM EasternExtended Trading$22.56 +0.03 (+0.11%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.68Holdings in IDNA have an aggregate rating of Moderate Buy based on 238 analyst ratings issued in the past year covering 17 companies (56.2% of the portfolio).IDNA Aggregate Price Target$22.56-0.11% DownsideHigh Prediction$22.56Average Prediction$22.56Low Prediction$22.56Holdings in IDNA have an aggregate price target of $22.56 and a range of $22.56 to $22.56 covering 17 companies (56.2% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy6 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.58%REGNRegeneron Pharmaceuticals$598.16+1.2%4.8414 of 5 stars2.81$829.65 38.7%26Positive NewsDividend AnnouncementEx-Dividend4.51%INCYIncyte$86.53+0.4%4.6957 of 5 stars2.33$81.20 -6.2%18Positive News4.46%MRNAModerna$26.22-2.5%4.3827 of 5 stars2.04$43.59 66.2%244.40%TWSTTwist Bioscience$26.47+0.1%4.1368 of 5 stars2.73$49.40 86.6%11Positive News4.34%ACLXArcellx$71.77+0.4%2.094 of 5 stars3.13$114.31 59.3%154.10%BNTXBioNTech$110.77-0.5%1.6541 of 5 stars2.76$135.80 22.6%17Analyst Revision4.10%MRKMerck & Co., Inc.$86.06+1.7%4.9723 of 5 stars2.35$107.44 24.8%20Positive NewsAnalyst Revision3.76%RVMDRevolution Medicines$36.48+0.9%4.3638 of 5 stars3.00$69.92 91.7%13Trending NewsAnalyst ForecastAnalyst Revision3.49%EXELExelixis$38.71+2.2%4.8976 of 5 stars2.55$44.06 13.8%22Trending NewsAnalyst Revision3.05%BCRXBioCryst Pharmaceuticals$8.384.1866 of 5 stars2.90$16.70 99.3%102.83%CELCCelcuity$50.38+3.3%1.0085 of 5 stars3.00$50.60 0.4%5Earnings ReportAnalyst ForecastShort Interest ↑High Trading Volume2.78%JANXJanux Therapeutics$24.00-3.5%2.2465 of 5 stars3.08$86.90 262.1%13Analyst Forecast2.34%ABCLAbCellera Biologics$4.30+3.1%2.2902 of 5 stars3.00$8.00 86.0%6Gap Up2.30%NVAXNovavax$7.63-12.7%4.6459 of 5 stars2.13$15.57 104.1%8Trending NewsAnalyst ForecastOptions VolumeGap DownHigh Trading Volume1.89%IMNMImmunome$9.95+4.0%1.8463 of 5 stars3.00$23.14 132.6%71.63%IOVAIovance Biotherapeutics$2.54+0.4%4.8122 of 5 stars2.36$11.90 368.5%14News CoverageAnalyst ForecastShort Interest ↓1.62%GERNGeron$1.43+2.9%3.1153 of 5 stars2.56$4.19 192.8%9Gap Up This page (NYSEARCA:IDNA) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access